The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases

BACKGROUND: In 2007, the priority review voucher (PRV) was implemented in the US to incentivize research and development (R&D) for tropical diseases. The PRV is issued by the US FDA and grants a quicker review to manufacturers upon successful development of a product for a disease eligible for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aerts, Celine, Barrenho, Eliana, Miraldo, Marisa, Sicuri, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217899/
https://www.ncbi.nlm.nih.gov/pubmed/35588350
http://dx.doi.org/10.1007/s40290-022-00427-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217899/
https://www.ncbi.nlm.nih.gov/pubmed/35588350
http://dx.doi.org/10.1007/s40290-022-00427-x

Ejemplares similares